Effect of anaemia on the response to preoperative chemoradiotherapy for rectal cancer.
anaemia
haemoglobin
radiation therapy
rectal cancer
response
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
27
11
2020
received:
20
10
2020
accepted:
22
12
2020
pubmed:
7
1
2021
medline:
25
5
2021
entrez:
6
1
2021
Statut:
ppublish
Résumé
Radiation therapy with concurrent chemotherapy is an important treatment for rectal cancer, especially for advanced stage disease. Low serum haemoglobin levels are accepted as a negative indicator in the response to radiation therapy. This study aimed to evaluate the relationship between anaemia and the response to preoperative chemoradiotherapy for rectal cancer and its effect on oncologic outcomes. We retrospectively reviewed medical records of primary rectal cancer patients who were treated with preoperative chemoradiotherapy followed by total mesorectal excision between January 2011 and December 2015. Anaemia was defined as serum haemoglobin levels ≤9 g/dL before or during radiotherapy. Patients were divided into good and poor responders according to pathologic tumour regression grades. The effect of anaemia on the response to radiation therapy, recurrence-free survival and overall survival were analysed after subgroup analysis. Overall, 301 and 394 patients were categorized into good and poor responder groups, respectively. Proportions of anaemia patients were higher in the poor responder group than in the good responder group (7.6% versus 4.0%, P = 0.042). Anaemia was associated with less pathologic complete regression but was not a risk factor for worse recurrence-free or overall survival. There was no significant difference in survival between patients with and without anaemia. Haemoglobin levels ≤9 g/dL before or during radiotherapy were risk factors for achieving pathologic complete regression after preoperative chemoradiotherapy for rectal cancer. However, anaemia was not independently associated with worse survival outcomes.
Sections du résumé
BACKGROUNDS
Radiation therapy with concurrent chemotherapy is an important treatment for rectal cancer, especially for advanced stage disease. Low serum haemoglobin levels are accepted as a negative indicator in the response to radiation therapy. This study aimed to evaluate the relationship between anaemia and the response to preoperative chemoradiotherapy for rectal cancer and its effect on oncologic outcomes.
METHODS
We retrospectively reviewed medical records of primary rectal cancer patients who were treated with preoperative chemoradiotherapy followed by total mesorectal excision between January 2011 and December 2015. Anaemia was defined as serum haemoglobin levels ≤9 g/dL before or during radiotherapy. Patients were divided into good and poor responders according to pathologic tumour regression grades. The effect of anaemia on the response to radiation therapy, recurrence-free survival and overall survival were analysed after subgroup analysis.
RESULTS
Overall, 301 and 394 patients were categorized into good and poor responder groups, respectively. Proportions of anaemia patients were higher in the poor responder group than in the good responder group (7.6% versus 4.0%, P = 0.042). Anaemia was associated with less pathologic complete regression but was not a risk factor for worse recurrence-free or overall survival. There was no significant difference in survival between patients with and without anaemia.
CONCLUSION
Haemoglobin levels ≤9 g/dL before or during radiotherapy were risk factors for achieving pathologic complete regression after preoperative chemoradiotherapy for rectal cancer. However, anaemia was not independently associated with worse survival outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E286-E291Informations de copyright
© 2021 Royal Australasian College of Surgeons.
Références
Roh MS, Colangelo LH, O'Connell MJ et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J. Clin. Oncol. 2009; 27: 5124-30.
van Gijn W, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011; 12: 575-82.
Patel UB, Taylor F, Blomqvist L et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J. Clin. Oncol. 2011; 29: 3753-60.
Garcia-Aguilar J, Chow OS, Smith DD et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015; 16: 957-66.
Lefevre JH, Mineur L, Kotti S et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6). J. Clin. Oncol. 2016; 34: 3773-80.
Shasha D. The negative impact of anemia on radiotherapy and chemoradiation outcomes. Semin. Hematol. 2001; 38: 8-15.
Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002; 7: 492-508.
Alarcon R, Koumenis C, Geyer RK, Maki CG, Giaccia AJ. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res. 1999; 59: 6046-51.
Hoff CM. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncol. 2012; 51: 419-32.
Welsh L, Panek R, Riddell A et al. Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck. Br. J. Cancer 2017; 116: 28-35.
Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int. J. Radiat. Oncol. Biol. Phys. 2005; 63: 25-36.
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 1997; 12: 19-23.
Becker A, Stadler P, Lavey RS et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 2000; 46: 459-66.
Walrand S, Lhommel R, Goffette P, van den Eynde M, Pauwels S, Jamar F. Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy. EJNMMI Res. 2012; 2: 20.
Lee SD, Park JW, Park KS et al. Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer. Int. J. Colorectal Dis. 2009; 24: 1451-8.
McGrane JM, Humes DJ, Acheson AG, Minear F, Wheeler JMD, Walter CJ. Significance of anemia in outcomes after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Clin. Colorectal Cancer 2017; 16: 381-5.
Liu H-C, Huang M-Y, Wang J-Y, Chang L-S, Lin S-R. The impact of white blood cell count and hemoglobin level on the response to radiotherapy in patients with colorectal cancer. Biomark. Genom. Med. 2014; 6: 171-4.
Nordsmark M, Bentzen SM, Rudat V et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother. Oncol. 2005; 77: 18-24.
Aapro M, Beguin Y, Bokemeyer C et al. Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. Ann. Oncol. 2018; 29: iv96-iv110.
Wilson MJ, Dekker JW, Bruns E et al. Short-term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study. Transfusion 2018; 58: 795-803.
Wilson MJ, Dekker JWT, Harlaar JJ, Jeekel J, Schipperus M, Zwaginga JJ. The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment. Int. J. Colorectal Dis. 2017; 32: 1617-24.
Gemici C, Yetmen O, Yaprak G et al. Is there any role of intravenous iron for the treatment of anemia in cancer? BMC Cancer 2016; 16: 661.
Wilson MJ, Harlaar JJ, Jeekel J, Schipperus M, Zwaginga JJ. Iron therapy as treatment of anemia: a potentially detrimental and hazardous strategy in colorectal cancer patients. Med. Hypotheses 2018; 110: 110-3.
Heiss MM, Mempel W, Jauch KW et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-33.
Busch O, Hop W, van Papendrecht MH, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N. Engl. J. Med. 1993; 328: 1372-6.
Smith JJ, Strombom P, Chow OS et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019; 5: 185896.
Tan Y, Fu D, Li D et al. Predictors and risk factors of pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer: a population-based analysis. Front. Oncol. 2019; 9: 497.